Preferences and user experience of wearable devices in cardiac rehabilitation: a systematic review and mixed-methods synthesis protocol Authors: Rongxiang Zhang, Linjing Wu, Pingping Huang, Shiqi Chen, Feng Tian, Yuan Chen Published: 2026 ABSTRACT AbstractBackgroundCardiac rehabilitation (CR) is an essential intervention for improving prognosis in patients with cardiovascular diseases. Despite its proven benefits, participation remains suboptimal due to time, geographic, and resource constraints. Wearable devices have emerged as promising tools to support home- and community-based CR by enabling continuous monitoring and personalized feedback. However, evidence on their effectiveness, user preferences, and experiences is inconsistent, and existing research often overlooks patients’ subjective perceptions. Understanding these experiences is crucial for optimizing device design and promoting sustained use.MethodsThis systematic review and mixed-methods synthesis has been prospectively registered in PROSPERO (registration number: CRD420251170358) and will be reported in accordance with the PRISMA-P and PRISMA 2020 reporting guidelines. Eligible studies will include quantitative, qualitative, and mixed-methods research focusing on the use of non-invasive wearable devices among CR patients, healthcare providers, or caregivers. Databases including PubMed, Embase, CINAHL, Cochrane Library, CNKI, Wanfang, VIP, and SinoMed will be searched from inception to October 2025, complemented by gray literature and trial registries. Two reviewers will independently conduct study selection, data extraction, and risk of bias assessment using Cochrane RoB 2.0, ROBINS-I, and JBI tools. Quantitative data will be summarized descriptively and, where appropriate, meta-analyzed using random-effects models. Qualitative findings will be synthesized through thematic analysis guided by the Technology Acceptance Model and integrated with quantitative results using a convergent mixed-methods approach.DiscussionThis review will synthesize current evidence on user preferences, experiences, and determinants related to wearable devices in cardiac rehabilitation. The anticipated findings are expected to clarify how factors such as comfort, usability, privacy, and trust influence acceptance and adherence. By integrating quantitative and qualitative evidence, the review will provide a more comprehensive understanding of technology use in CR. These insights may inform patient-centered device design, guide clinical implementation strategies, and highlight priorities for future research and digital health innovation.Systematic review registrationPROSPERO CRD420251170358.Keywords: Cardiac rehabilitation, Wearable devices, User experience, Patient preferences, Mixed-methods systematic review Introduction Rationale Cardiac rehabilitation is a key intervention for preventing and improving the prognosis of patients with cardiovascular diseases, with core components including exercise training, risk factor control, and psychosocial support [1, 2]. Studies have shown that regular participation in cardiac rehabilitation can significantly reduce the recurrence of cardiovascular events and improve exercise capacity and quality of life [3–5]. However, participation rates remain low in real-world practice, especially after hospital discharge. Limited by factors such as time, geography, healthcare resources, and individual adherence, traditional face-to-face rehabilitation programs face multiple challenges [6, 7]. In recent years, wearable devices, as an essential component of digital health, have provided new technological pathways for cardiac rehabilitation [8]. Through sensor technologies, they enable real-time monitoring of physiological parameters such as heart rate, step count, energy expenditure, and activity level, allowing patients to continue rehabilitation training in home and community settings [9]. Moreover, their intelligent feedback and remote monitoring functions help healthcare professionals dynamically assess rehabilitation outcomes and promote individualized interventions [3, 10]. However, existing studies show considerable variability in the effectiveness of wearable devices in cardiac rehabilitation—some report significant improvements in adherence and exercise performance, while others reveal poor user experience and even resistance among patients [11, 12]. User preference and experience are key determinants of the acceptance and long-term use of wearable devices [13]. Factors such as comfort, interface usability, data security, and psychological acceptance directly influence whether patients continue using these technologies. However, most current research focuses on device performance or short-term outcomes, with a lack of systematic synthesis and cross-study integration of patients’ real experiences. Quantitative studies provide statistical evidence but often overlook subjective perceptions; qualitative studies reveal deeper psychological and behavioral mechanisms but are limited by small sample sizes and restricted generalizability. Therefore, a mixed-methods systematic review integrating quantitative and qualitative evidence can provide a more comprehensive understanding of cardiac rehabilitation patients’ preferences, experiences, and the factors influencing their use of wearable devices. In summary, this review aims to systematically synthesize existing literature from the patient perspective to explore user preferences and experiences with wearable devices in cardiac rehabilitation. It seeks to identify the advantages, barriers, and directions for improvement in their application, thereby providing evidence-based support for optimizing the design and clinical implementation of wearable health technologies in the future. Objectives The primary objective of this review is to synthesize evidence on user experience and acceptance of non-invasive wearable devices among individuals participating in cardiac rehabilitation. Secondary objectives are to examine (1) user preferences and perceived usability as antecedent evaluative constructs that may shape acceptance, (2) adherence and actual use as behavioral manifestations of acceptance, and (3) facilitators and barriers as explanatory factors influencing both acceptance and sustained engagement. By structuring these domains hierarchically, the review aims to clarify the relationships between perceived device attributes, behavioral intention, and real-world technology use within cardiac rehabilitation contexts. Methods This protocol has been prospectively registered with the International Prospective Register of Systematic Reviews (PROSPERO; registration number: CRD420251170358). The conduct of this review will be guided by the Joanna Briggs Institute (JBI) Manual for Evidence Synthesis [14]. The reporting of this protocol adheres to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines [15]. Eligibility criteria Types of studies We will include randomized controlled trials, quasi-experimental studies, observational studies (cohort, case–control, and cross-sectional), mixed-methods studies, and qualitative research. We will exclude case reports/series, technical validation or methodological studies, reviews, commentaries, editorials, study protocols, animal studies, and conference abstracts. Only peer-reviewed full-text articles will be included. Types of participants The target population of the included studies will consist of individuals undergoing cardiac rehabilitation and patients diagnosed with cardiovascular diseases, such as coronary heart disease or heart failure, together with healthcare professionals or caregivers engaged in cardiac rehabilitation practice. Intervention content This review will focus on non-invasive wearable devices used to support cardiac rehabilitation. To enhance analytic coherence and reduce heterogeneity, wearable devices will be classified a priori into functional categories based on their primary monitoring and interaction characteristics. Devices will be grouped into the following functional classes: ① Activity-focused trackers: devices primarily designed to monitor physical activity metrics such as step count, energy expenditure, and movement patterns (e.g., wrist-worn fitness trackers). ① Activity-focused trackers: devices primarily designed to monitor physical activity metrics such as step count, energy expenditure, and movement patterns (e.g., wrist-worn fitness trackers). ② Heart-rate monitoring devices: wearables that primarily provide continuous or intermittent heart rate monitoring, including chest straps or optical heart-rate wrist devices. ② Heart-rate monitoring devices: wearables that primarily provide continuous or intermittent heart rate monitoring, including chest straps or optical heart-rate wrist devices. ③ ECG-capable smart devices: smartwatches or patches capable of recording single-lead or multi-lead electrocardiographic signals in addition to activity monitoring. ③ ECG-capable smart devices: smartwatches or patches capable of recording single-lead or multi-lead electrocardiographic signals in addition to activity monitoring. ④ Multi-sensor integrated systems: wearable systems combining multiple physiological signals (e.g., heart rate, ECG, blood pressure, oxygen saturation, respiration) and often linked to remote monitoring platforms. ④ Multi-sensor integrated systems: wearable systems combining multiple physiological signals (e.g., heart rate, ECG, blood pressure, oxygen saturation, respiration) and often linked to remote monitoring platforms. When device functionality overlaps across categories, classification will be based on the device’s primary intended function within the study context. This taxonomy will guide subgroup analyses and support interpretation of both quantitative and qualitative findings. Studies primarily evaluating implantable cardiac devices (e.g., pacemakers or ICDs) as the intervention or monitoring technology will be excluded. However, studies in which participants have an implanted device but use a separate non-invasive wearable will remain eligible. Study outcomes To enhance conceptual clarity and analytic coherence, outcomes in this review will be organized hierarchically, distinguishing primary evaluative constructs from secondary explanatory constructs. All predefined outcome domains, including preferences and behavioral use indicators, will be systematically extracted and synthesized. Primary outcome domain.The primary outcome of interest is user experience and acceptance of wearable devices in cardiac rehabilitation. This domain encompasses participants’ overall perceptions, satisfaction, perceived usefulness, perceived ease of use, and behavioral intention to use the device. Where reported, validated usability or acceptance scales (e.g., System Usability Scale or technology acceptance measures) will be prioritized.Acceptance will be conceptualized as the attitudinal and intentional readiness to adopt and continue using the device. Primary outcome domain. The primary outcome of interest is user experience and acceptance of wearable devices in cardiac rehabilitation. This domain encompasses participants’ overall perceptions, satisfaction, perceived usefulness, perceived ease of use, and behavioral intention to use the device. Where reported, validated usability or acceptance scales (e.g., System Usability Scale or technology acceptance measures) will be prioritized. Acceptance will be conceptualized as the attitudinal and intentional readiness to adopt and continue using the device. (2)Secondary explanatory domains.① Antecedent perceptions.This domain includes user preferences (as a prespecified outcome construct) and perceived usability, representing cognitive evaluations of device characteristics that may shape acceptance. Dimensions may include device type, functional features (e.g., heart rate or ECG monitoring), design aesthetics, comfort, affordability, and perceived cost-effectiveness.② Behavioral outcomes (actual use).Adherence and actual use will be treated as behavioral manifestations of acceptance. Adherence may be operationalized as wearing time, frequency of use, completion of prescribed sessions, program retention, or sustained engagement over time, depending on study definitions.③ Facilitators and barriers.Facilitators and barriers will be considered explanatory determinants influencing both acceptance and adherence. These may include device-related factors (e.g., technical reliability, battery life), contextual factors (e.g., rehabilitation setting, clinician support), and psychosocial factors (e.g., trust, privacy concerns, social support).By structuring outcomes in this hierarchical framework, the review aims to distinguish between perceived device attributes, attitudinal acceptance, and observable behavioral engagement, thereby improving conceptual coherence and analytic transparency. Secondary explanatory domains.① Antecedent perceptions.This domain includes user preferences (as a prespecified outcome construct) and perceived usability, representing cognitive evaluations of device characteristics that may shape acceptance. Dimensions may include device type, functional features (e.g., heart rate or ECG monitoring), design aesthetics, comfort, affordability, and perceived cost-effectiveness.② Behavioral outcomes (actual use).Adherence and actual use will be treated as behavioral manifestations of acceptance. Adherence may be operationalized as wearing time, frequency of use, completion of prescribed sessions, program retention, or sustained engagement over time, depending on study definitions.③ Facilitators and barriers.Facilitators and barriers will be considered explanatory determinants influencing both acceptance and adherence. These may include device-related factors (e.g., technical reliability, battery life), contextual factors (e.g., rehabilitation setting, clinician support), and psychosocial factors (e.g., trust, privacy concerns, social support).By structuring outcomes in this hierarchical framework, the review aims to distinguish between perceived device attributes, attitudinal acceptance, and observable behavioral engagement, thereby improving conceptual coherence and analytic transparency. ① Antecedent perceptions.This domain includes user preferences (as a prespecified outcome construct) and perceived usability, representing cognitive evaluations of device characteristics that may shape acceptance. Dimensions may include device type, functional features (e.g., heart rate or ECG monitoring), design aesthetics, comfort, affordability, and perceived cost-effectiveness. ① Antecedent perceptions. This domain includes user preferences (as a prespecified outcome construct) and perceived usability, representing cognitive evaluations of device characteristics that may shape acceptance. Dimensions may include device type, functional features (e.g., heart rate or ECG monitoring), design aesthetics, comfort, affordability, and perceived cost-effectiveness. ② Behavioral outcomes (actual use).Adherence and actual use will be treated as behavioral manifestations of acceptance. Adherence may be operationalized as wearing time, frequency of use, completion of prescribed sessions, program retention, or sustained engagement over time, depending on study definitions. ② Behavioral outcomes (actual use). Adherence and actual use will be treated as behavioral manifestations of acceptance. Adherence may be operationalized as wearing time, frequency of use, completion of prescribed sessions, program retention, or sustained engagement over time, depending on study definitions. ③ Facilitators and barriers.Facilitators and barriers will be considered explanatory determinants influencing both acceptance and adherence. These may include device-related factors (e.g., technical reliability, battery life), contextual factors (e.g., rehabilitation setting, clinician support), and psychosocial factors (e.g., trust, privacy concerns, social support).By structuring outcomes in this hierarchical framework, the review aims to distinguish between perceived device attributes, attitudinal acceptance, and observable behavioral engagement, thereby improving conceptual coherence and analytic transparency. ③ Facilitators and barriers. Facilitators and barriers will be considered explanatory determinants influencing both acceptance and adherence. These may include device-related factors (e.g., technical reliability, battery life), contextual factors (e.g., rehabilitation setting, clinician support), and psychosocial factors (e.g., trust, privacy concerns, social support). By structuring outcomes in this hierarchical framework, the review aims to distinguish between perceived device attributes, attitudinal acceptance, and observable behavioral engagement, thereby improving conceptual coherence and analytic transparency. Search strategy The literature search will be conducted by an information specialist with expertise in systematic review searches, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses literature search extension (PRISMA-S) guidelines. To ensure methodological rigor and comprehensiveness, the search strategy will undergo peer review by another experienced information specialist using the Peer Review of Electronic Search Strategies (PRESS) checklist. Searches will encompass both English and Chinese databases and will be developed using a combination of controlled vocabulary terms (e.g., MeSH, Emtree, CINAHL Headings, and Chinese subject terms) and free-text keywords. The detailed PubMed search strategy is presented in the online supplemental material (Appendix 1). Information sources The following databases will be systematically searched: PubMed, Embase, CINAHL, and the Cochrane Library for English-language literature; and China National Knowledge Infrastructure (CNKI), Wanfang Data, VIP, and the Chinese Biomedical Literature Database (SinoMed) for Chinese-language literature. The search will cover all databases from inception to October 2025. To ensure currency of the evidence, we will rerun the searches immediately before data extraction and again prior to final synthesis, and the search date will be updated accordingly. Search strategies will be developed using both controlled vocabulary (e.g., MeSH, Emtree) and free-text keywords, encompassing core concepts such as “cardiac rehabilitation,” “wearable devices,” “user experience,” and “patient preferences.” To ensure comprehensive coverage, additional searches will be performed in clinical trial registries and grey literature sources, including ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform (ICTRP), to identify unpublished or ongoing studies. Reference lists of included studies and relevant systematic reviews will be screened using a snowballing approach to identify further eligible publications. Conference proceedings, dissertations, and reports from relevant institutional websites that meet the inclusion criteria will also be considered. Study records Literature screening The literature screening will be independently conducted by two reviewers trained in systematic review methodology to ensure scientific rigor and consistency. The screening process will be performed in three stages. First, all retrieved records will be imported into NoteExpress reference management software, and duplicates will be automatically removed; manual verification will then be performed to ensure accuracy. Second, titles and abstracts will be screened to exclude studies that are clearly irrelevant or fail to meet the inclusion criteria. Finally, the full texts of potentially eligible studies will be reviewed in detail to determine their eligibility based on the predefined inclusion and exclusion criteria. Any disagreements between reviewers will be resolved through discussion or consultation with a third reviewer to reach consensus. The screening results will be reported using a PRISMA 2020 flow diagram, illustrating the number of records identified, screened, excluded, and ultimately included at each stage. For excluded full-text articles, the main reasons for exclusion will be documented and reported to ensure transparency and reproducibility of the selection process. Data extraction Data extraction will be conducted independently by two reviewers to ensure accuracy and consistency of data collection. A predesigned data extraction form will be developed for this review, which will include the following elements: basic study characteristics (e.g., author, publication year, country, study objectives, design, sample size, and participant characteristics); intervention details or device types (e.g., type of wearable device, functions, and mode of use); primary outcome indicators (e.g., user experience, acceptability, adherence, satisfaction, and preference factors); and main study findings. During the extraction process, the two reviewers will independently extract all relevant information from the included studies. Any discrepancies or inconsistencies identified during data extraction will be resolved through discussion and, if necessary, adjudicated by a third reviewer. When data are incomplete or unclear, attempts will be made to contact the original authors via email for additional information or clarification. All extracted data will be entered into a database created in Microsoft Excel for subsequent descriptive and integrative analyses. For qualitative studies, data related to themes such as user experience, barriers to use, and factors influencing preferences will be prioritized. For quantitative studies, key statistical results (e.g., means, standard deviations, proportions, or effect sizes) will be extracted to support subsequent synthesis and analysis. When multiple publications arise from the same study population or dataset, companion papers will be identified by cross-checking author names, study characteristics, trial registration numbers, recruitment periods, and sample descriptions. In such cases, the most comprehensive and methodologically robust report will be considered the primary source for quantitative data extraction. Additional publications will be used to supplement contextual, methodological, or qualitative information but will not contribute duplicate participant data to quantitative synthesis. Risk of bias assessment The risk of bias assessment for the included studies will be conducted independently by two reviewers with formal training in systematic review methodology. The selection of assessment tools will be determined according to the type of study design. Any discrepancies between the two reviewers will be resolved through discussion, and if consensus cannot be reached, a third reviewer will arbitrate to ensure objectivity and consistency throughout the evaluation process. For randomized controlled trials, the Cochrane Risk of Bias Tool 2.0 will be used for assessment [16]. The evaluation will cover six domains: (1) bias arising from the randomization process; (2) bias due to deviations from intended interventions; (3) bias due to missing outcome data; (4) bias in measurement of the outcome; (5) bias in selection of the reported result; and (6) overall risk of bias. Each domain will be judged as “low risk,” “some concerns,” or “high risk,” and the overall risk of bias will be determined based on these domain-level judgments. For non-randomized studies (such as cross-sectional, cohort, or case–control designs), the ROBINS-I tool will be employed for quality assessment [17]. This tool evaluates seven domains, including confounding, selection of participants, classification of interventions, deviations from intended interventions, missing data, measurement of outcomes, and selection of reported results. Studies found to have serious or critical risk of bias will be excluded from quantitative synthesis. For qualitative studies, the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Qualitative Research will be applied [18], focusing on dimensions such as clarity of research objectives, appropriateness of methodology, researcher reflexivity, transparency in data collection and analysis, and coherence between data and conclusions. Risk of bias assessments will inform not only eligibility for quantitative pooling but also the interpretation of narrative findings. Studies judged as having serious or critical risk of bias will not be excluded from narrative synthesis; however, their findings will be clearly identified and interpreted with caution. Greater interpretive weight will be assigned to findings derived from studies assessed as low risk of bias, in order to enhance transparency and methodological rigor in the overall synthesis. In addition, the GRADE approach will be used to rate the certainty of evidence for the main quantitative outcomes [19], while the GRADE-CERQual (Confidence in the Evidence from Reviews of Qualitative research) method will be used to assess the confidence in synthesized qualitative findings [20]. The latter will consider methodological limitations, coherence, adequacy, and relevance of the data. Finally, the overall evidence profile will be summarized and presented in tabular form, providing a clear and evidence-based foundation for the interpretation and clinical application of the study findings. Data synthesis and analysis This review will adopt a convergent integrated mixed-methods synthesis framework to comprehensively integrate findings from quantitative and qualitative studies [14, 21]. Quantitative and qualitative data will first be analyzed separately and subsequently integrated to generate a coherent understanding of user experience, acceptance, and engagement with wearable devices in cardiac rehabilitation. The primary unit of synthesis will be the individual study. For descriptive and narrative analyses, each included study will be treated as a single unit of evidence. For quantitative meta-analysis, however, the analytic unit will be the independent intervention arm when multiple wearable device types or distinct intervention groups are reported with separate outcome data. In such cases, eligible intervention arms will be included separately. Shared comparator groups will be adjusted appropriately (e.g., proportional splitting of the control group) to prevent double counting. Quantitative analyses will be conducted separately according to study design. Randomized controlled trials and non-randomized observational studies will not be pooled within the same meta-analysis. Descriptive statistics will summarize study characteristics (e.g., sample size, country, study design, device type) and key outcomes (e.g., acceptance scores, adherence rates, preference proportions). To enhance outcome harmonization, predefined operational criteria will be applied. Adherence will be categorized into standardized indicators where feasible, including (1) device wear time, (2) frequency of use, (3) completion of prescribed rehabilitation sessions, and (4) program retention or sustained engagement. When multiple adherence metrics are reported, the primary adherence definition used by the original study will be extracted, with additional metrics recorded for sensitivity analysis. For usability, satisfaction, and acceptance measures, validated instruments (e.g., System Usability Scale or technology acceptance scales) will be prioritized. When conceptually similar constructs are measured using different continuous scales, standardized mean differences (SMDs) will be calculated to enable pooling. If instruments differ substantially in conceptual scope or measurement properties, findings will be synthesized narratively. Ordinal Likert-type data will be treated as continuous only when appropriate statistical assumptions and reporting permit. Meta-analysis will be considered when at least three studies of comparable design report conceptually equivalent outcomes measured using sufficiently similar definitions or validated tools and provide adequate statistical information. When pooling is appropriate, a random-effects model will be applied to account for anticipated clinical and methodological heterogeneity. Statistical heterogeneity will be evaluated using the I2 statistic. Assessment of small-study effects and potential publication bias (e.g., funnel plot asymmetry, Egger’s test) will be conducted only when ten or more studies are included in a given meta-analysis. Subgroup analyses will be prespecified according to the functional taxonomy of wearable devices (activity-focused trackers, heart rate monitoring devices, ECG-capable smart devices, and multi-sensor integrated systems). Where sufficient data are available, additional subgroup analyses will be performed based on rehabilitation setting (inpatient, home-based, hybrid) and study design. Rehabilitation setting will be treated as a moderator variable, given its potential influence on supervision intensity, environmental support, patient autonomy, and technology engagement. For qualitative studies, thematic analysis will be conducted using NVivo software [22]. Initial coding will be guided by the research questions and the Technology Acceptance Model (TAM) [23], focusing on perceived usefulness, perceived ease of use, attitude toward use, behavioral intention, and actual use. Themes will be iteratively developed to capture user preferences, experiential factors, adherence-related behaviors, and facilitators or barriers. Contextual factors, particularly rehabilitation setting, will be explicitly examined to understand how environmental and organizational conditions shape acceptance and engagement. Finally, quantitative and qualitative findings will be integrated using a convergent approach consistent with the JBI framework [14, 21]. Quantitative results will first be summarized within design categories and interpreted in light of methodological rigor and risk-of-bias assessments. These findings will then be conceptually aligned with TAM-guided qualitative themes to identify convergence, complementarity, and discrepancies. Studies with serious methodological limitations will be interpreted cautiously and primarily used to generate explanatory insights rather than confirmatory conclusions. Exploratory text-mining techniques (e.g., TF-IDF keyword visualization) may be used to support transparency but will not replace formal mixed-methods integration. Assessment of reporting biases This review will evaluate the potential presence of publication bias and selective reporting bias among the included studies. For studies included in the quantitative synthesis (e.g., meta-analysis), when ten or more studies are available for a given outcome, funnel plots will be generated to visually assess publication bias. In addition, Egger’s regression test and Begg’s rank correlation test will be conducted to statistically examine asymmetry. If evidence of bias is detected—such as asymmetrical funnel plots or significant test results—the Trim-and-Fill method will be applied to estimate and adjust for the potential impact of missing studies [24]. For qualitative studies, potential selective reporting bias will be assessed by comparing each study’s stated objectives with its reported results to identify discrepancies. Moreover, the transparency and completeness of reporting will be evaluated using the GRADE-CERQual framework to ensure the robustness of qualitative evidence [25]. All findings from the bias assessments will be reported in detail to ensure the objectivity, transparency, and credibility of the systematic review conclusions. Discussion This review is expected to provide a comprehensive synthesis of preferences, user experiences, and determinants related to wearable devices in cardiac rehabilitation. By integrating quantitative and qualitative evidence, we aim to clarify how factors such as usability, perceived usefulness, comfort, privacy, and patient–clinician interaction influence acceptance and sustained use. These findings will support a better understanding of how wearable technologies can be more effectively incorporated into rehabilitation practice. In recent years, wearable devices have attracted increasing interest as adjuncts to cardiac rehabilitation [8], enabling remote monitoring, real-time feedback, and personalized guidance [9, 26]. However, variability in acceptance, adherence, and user experience remains substantial and limits broader implementation [27, 28]. Our mixed-methods approach is designed to address this gap by combining statistical evidence with patients’ subjective perspectives, thereby offering a more comprehensive interpretation of technology use in real-world settings. The anticipated synthesis is expected to reveal both facilitators and barriers, including comfort, interface usability, technological trust, and data security concerns, as well as contextual influences such as support from clinicians and family members [8, 29]. Qualitative findings are likely to illuminate psychological and contextual processes underlying technology use, while quantitative evidence may help compare different device types or models of delivery and inform personalized rehabilitation strategies. Despite these strengths, several challenges are anticipated. Heterogeneity across device types, rehabilitation phases, and study methodologies may complicate synthesis, and incomplete reporting or small sample sizes could reduce certainty of evidence. In addition, integration of quantitative and qualitative findings inevitably involves interpretive judgment, which may introduce potential bias. Nevertheless, the use of comprehensive search strategies, standardized critical appraisal tools, and GRADE/GRADE-CERQual assessments will help strengthen methodological rigor. Taken together, this review is expected to contribute to a clearer understanding of how wearable devices are perceived and used within cardiac rehabilitation. The findings may inform patient-centered device design, guide clinical implementation strategies, and highlight priority areas for future research—particularly regarding long-term adherence and equitable access to digital health technologies. Acknowledgements Not applicable. Appendix 1 Pubmed Search strategy: Cardiac rehabilitation[MeSH Terms] Cardiac rehabilitation[MeSH Terms] Heart failure[MeSH Terms] Heart failure[MeSH Terms] Coronary artery disease[MeSH Terms] Coronary artery disease[MeSH Terms] Cardiovascular disease[MeSH Terms] Cardiovascular disease[MeSH Terms] Cardiac rehabilitation[Title/Abstract] Cardiac rehabilitation[Title/Abstract] Heart failure[Title/Abstract] Heart failure[Title/Abstract] Coronary artery disease[Title/Abstract] Coronary artery disease[Title/Abstract] Cardiovascular disease[Title/Abstract] Cardiovascular disease[Title/Abstract] OR/1—8 OR/1—8 Wearable Electronic Devices[MeSH Terms] Wearable Electronic Devices[MeSH Terms] Fitness tracker[MeSH Terms] Fitness tracker[MeSH Terms] Wearable[Title/Abstract] Wearable[Title/Abstract] Wearable device Wearable device Smartwatch[Title/Abstract] Smartwatch[Title/Abstract] Fitness tracker[Title/Abstract] Fitness tracker[Title/Abstract] Smart insole Smart insole IMU[Title/Abstract] IMU[Title/Abstract] Wearable sensor[Title/Abstract] Wearable sensor[Title/Abstract] OR/10–18 OR/10–18 Patient Preference[MeSH Terms] Patient Preference[MeSH Terms] Patient Preference Patient Preference User experience[Title/Abstract] User experience[Title/Abstract] Preference[Title/Abstract] Preference[Title/Abstract] Acceptance[Title/Abstract] Acceptance[Title/Abstract] Usability[Title/Abstract] Usability[Title/Abstract] Adherence[Title/Abstract] Adherence[Title/Abstract] Satisfaction[Title/Abstract] Satisfaction[Title/Abstract] Perception[Title/Abstract] Perception[Title/Abstract] OR/20–28 OR/20–28 Nine AND 19 AND 29 Nine AND 19 AND 29 Authors’ contributions This research protocol was jointly designed by ZRX, WLJ, and CY. The initial draft was prepared by ZRX and WLJ, with revisions made following review by CY. The search strategy was developed by HPP and CSQ and reviewed by TF. Key academic content of the manuscript was reviewed and revised by HPP, TF, CSQ, and CY. All authors approved the final manuscript prior to publication. Funding This review was supported by the Medical and Health Guiding Project of Xiamen, Fujian Province (Grant No. 3502Z20254ZD1342). The funder had no role in the design of the study, data collection and analysis, interpretation of data, or writing of the manuscript. Data availability Not applicable. Declarations Ethics approval and consent to participate This review is a systematic review and mixed-methods synthesis that relies solely on data from publicly available literature. As it does not involve human participants or animal experiments, ethical approval is not required. Consent for publication Not required. Competing interests The authors declare that they have no competing interests. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rongxiang Zhang and Linjing Wu contributed equally to this work. References Associated Data Data Availability Statement Not applicable.